Preparation and analysis of monotypic and organotypic tumor spheroids
Methods in Cell Biology · 2024
DOI: 10.1016/bs.mcb.2024.11.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Cell Biology, 2024. Verfasst von Ana Carolina M Domingues und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School,…. Hauptthemen laut MEDLINE: Spheroids, Cellular, Neoplasms, Cell Culture Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Patient-derived tumor models are emerging as promising tools to explore patient-specific tumor behavior and to address a central gap in tumor immunology and immunotherapy drug development - the need for clinically relevant tumor models that recapitulate the complexity of the human tumor ecosystem, in which cancer cells are interacting with various immune and stromal elements. Patient-derived organotypic tumor spheroids (PDOTS), a biomimetic 3D-patient tumor avatar (3D-PTA), are comprised of cancer cells and autologous tumor-infiltrating immune and stromal cells that are grown within collagen hydrogels embedded in a 3D microfluidic culture device to model physiologic conditions and enable the study of tumor-immune dynamics. PDOTS and their murine counterparts (MDOTS, murine-derived organotypic tumor spheroids) are responsive to immune checkpoint blockade (ICB) and mirror in vivo response dynamics. We have also confirmed the utility of MDOTS/PDOTS in examining novel therapeutic strategies to overcome ICB resistance and testing the efficiency of T cell-based immunotherapies, demonstrating the utility of PDOTS profiling in examining the tumor-immune dynamics of immunotherapy response and resistance. Here, we provide a detailed protocol for processing, ex vivo culture, and analysis of patient-derived tumor organotypic tumor spheroids (PDOTS) in 3D microfluidic culture for immuno-oncology applications. The protocol can be readily adapted for ex vivo profiling of murine-derived organotypic tumor spheroids (MDOTS) and cancer cell line-derived monotypic tumor spheroids (MTS) for robust and iterative testing of immuno-oncology targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Instituto do Câncer do Estado de São Paulo…
- Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
- Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Broad Institute of MIT and Harvard, Cambri…
Zitieren
APA
Domingues, A. C. M., Palin, C., Sun, Y., Xie, H., Woods, E. C., Jenkins, R. W., & Revach, O. Y. (2024). Preparation and analysis of monotypic and organotypic tumor spheroids. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.11.003
Vancouver
Domingues ACM, Palin C, Sun Y, Xie H, Woods EC, Jenkins RW, et al. Preparation and analysis of monotypic and organotypic tumor spheroids. Methods in Cell Biology. 2024. doi:10.1016/bs.mcb.2024.11.003
BibTeX
@article{Domingues2024,
author = {Domingues, Ana Carolina M and Palin, Claire and Sun, Yi and Xie, Hongyan and Woods, Elliot C and Jenkins, Russell W and Revach, Or-Yam},
title = {Preparation and analysis of monotypic and organotypic tumor spheroids},
journal = {Methods in Cell Biology},
year = {2024},
doi = {10.1016/bs.mcb.2024.11.003}
}
EUVIMED